Cancer Nursing Today Editors

Cancer Nursing Today nonprod

<p>Peter M. Voorhees, MD, of Atrium Health in Charlotte, North Carolina, discussed the emerging role of B-cell maturation&nbsp;antigen (BCMA)-targeted chimeric antigen receptor (CAR) T-cell treatment strategies in multiple myeloma presented at the 2019 ASH Annual Meeting. In particular, he discussed &ldquo;exciting preliminary data&rdquo; of a novel BCMA-bispecific antibody. The first-in-human study showed that a majority of patients are responding to therapy at higher dose levels. &ldquo;With relatively short follow-up, the results are really quite impressive,&rdquo; he said.</p>


“Impressive” Results in BCMA CAR T-Cell Therapy for Multiple Myeloma

Conferences

Peter M. Voorhees, MD, of Atrium Health in Charlotte, North Carolina

About Us

Editorial Policy

Authors

Advertising

eNewsletters

Contact Us

Contribute

Calendar of Events

Career Center

Blood Cancers Today

GU Oncology Now

DocWire News

MashupMD

Urban Health Today

Breast Cancer

Colorectal Cancer

GI Cancer

GU Cancer

Gynecologic Cancer Awareness Month

Gyn-Onc

Blood Cancer Awareness Month

GVHD

Leukemia

Lymphoma

Myeloproliferative Neoplasms

Multiple Myeloma

Myelodysplastic Syndrome

Myelofibrosis

Sickle Cell

Hem/Onc

Professional Development

Patient Voice

Lung Cancer

Skin Cancer

Other Tumor Types

News

Treatment

More

Calendar

CARE Award

Best Practices

Expert Interviews

Subscribe